Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Conferences 2020

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Tailor-made Pharma Solutions

Make better informed business decisions with customized pharmaceutical consulting and marketing services that give you the edge over your competition.

Tailor-made solutions

Use the expertise and experience of Pharma Intelligence to produce custom solutions that are actionable, flexible, and tailored to help you successfully navigate biopharma portfolio management, commercial optimization, and R&D strategy. Benefit from:

A customized approach – we develop solutions to fit your situation
Joint problem/opportunity definition
Proprietary data and complementary market research
The experience of 500+ industry experts
Collaborative problem solving
Fact-based decisions and actionable recommendations
Ownership of final decisions and action plans

Discover new business opportunities, reduce risks, and make better, faster decisions with tailor-made pharmaceutical solutions from Pharma Intelligence.

In Vivo, Medtech Insight, Pink Sheet, Scrip

The Rise of Digital Tools eBook

Explore how digital technologies are being used to address the disruption of clinical trials for drugs and medical technology caused by COVID-19. Stay current with insights from industry leaders, information on guidance and regulation, and an examination of how the challenges of this global crisis and the industry’s response to it may soon usher in a new era in worldwide healthcare.

Topic Coronavirus

View article
HBW Insight, Generics Bulletin, Medtech Insight, Datamonitor...

Pharma Intelligence Launches Alexa Skill

Keep up with topics you care about in Pharma and Medtech with the new Alexa Skill from Informa Pharma Intelligence. Now you can listen to our podcasts on subjects you choose, right from your Alexa smartphone app!

Topic Artificial Intelligence Consumer Innovation

View article
Citeline

The Future of Clinical Trials From the Investigator Perspective Webinar

Listen to our podcast “The Future of Clinical Trials From the Investigator Perspective” from earlier this year and register for our upcoming webinar to learn new developments

Topic Clinical Trials Coronavirus

View article
HBW Insight

Germany's Supplements Market Boosted By COVID-19

Infographic: COVID-19 delivers an 8% sales growth injection to Germany's supplements market in the first half of the year, accelerating a long-term expansion.

Topic Dietary Supplements Market Intelligence

View article
Generics Bulletin

WHO's Latest COVID Recommendations Show Generic Potential

World Health Organization recommendations to use dexamethasone and hydrocortisone to treat patients with severe and critical COVID-19 demonstrate the potential for common and low-cost generics in fighting the coronavirus pandemic.

Topic Coronavirus

View article
Medtech Insight

COVID-19: CDRH Staff Leaves Door Open For Some LDT Safety Oversight

US FDA staff spoke on HHS’s new laboratory developed test edict, as well as ongoing concerns around new test types and reviewer responsiveness in a recent virtual town hall.

Topic Coronavirus FDA

View article
Medtech Insight

Qiagen Ready To Rival Abbott With Rapid Portable Antigen COVID-19 Test

The diagnostics company said the test is scheduled for US launch in Q4 2020.

Topic Coronavirus Diagnostics In Vitro Diagnostics

View article
Scrip

Pharma Stands Up To Trump Pressure With COVID-19 Vaccines Science Pledge

CEOs from the most advanced vaccines developers pledge to maintain standards – for the sake of safety, efficacy and public trust in vaccines

Topic Clinical Trials

View article
Scrip

AstraZeneca's COVID Vaccine On Hold: A Reminder Drug Development Is Never Straightforward

The company – one of the frontrunners in the race to develop a COVID-19 vaccine – has voluntarily put a hold on the Phase III trial due to an adverse event.

Topic Coronavirus Vaccines

View article
Pink Sheet

UK Votes To Leave The EU – Where Next For The Life Sciences?

UK vote to leave the EU opens the prospect of years of negotiations over the union's future relationship with one of its most valued member states.

Topic Regulation Brexit BioPharmaceutical

View article
Generics Bulletin

Time Is Short To Prepare For New Post-Brexit UK Regulation

Guidance from the UK’s MHRA on post-Brexit arrangements relevant to the off-patent industry has been welcomed by local industry body the BGMA. However, it has warned that time is short to prepare for the end of the UK-EU transition period, with new guidance in certain areas “critical.”

Topic Brexit

View article
Medtech Insight

UKCA Mark Will Be The Post-EU Route To The British Medtech Market In January 2021

New MHRA guidance says the EU CE marking will continue to be used for devices and diagnostics in Great Britain until June 2023, and thereafter a standalone regulatory system will come into place.

Topic Medtech-Brexit Regulation

View article
Medtech Insight

Brexit Response: Patient Safety Prioritized In Forthcoming UK MHRA Device Regulatory System

Although the EU MDR and IVDR will fall outside the scope of new post-Brexit medtech regulations for Great Britain in 2021, the UK MHRA says it has the chance of developing its own world-leading regulatory regime.

Topic Medtech-Brexit Regulation Brexit

View article
Pink Sheet

UK Explains Approach To Renewing Converted EU Drug Approvals in 2021

The Medicines and Healthcare products Regulatory Agency has put procedures in place to renew UK marketing authorizations that are grandfathered from the EU system after the Brexit transition period ends.

Topic EU Pharma-Brexit Brexit

View article
Pink Sheet

Gloom Over Prospects For Brexit Trade Deal

With time running out on the UK-EU trade deal negotiations, the UK life sciences industry looks at the fine print of the new guidance on medicines regulation and explains why a mutual recognition agreement is urgently needed.

Topic Pharma-Brexit Regulation Brexit

View article

Latest headlines

Generics Bulletin

17 Sep 2020

Five More Circle Tecfidera With Ruling 'Unlikely To Be Reversed'

Link
Pink Sheet

17 Sep 2020

EMA Aims For Better Info On Benefit-Risk Balance To Support Drug Choices In Pregnancy

Link
Scrip

17 Sep 2020

Moderna Expands Horizons With Vertex and Chiesi Deals

Link
Scrip

17 Sep 2020

Executives On The Move: Changes At The Top At Silence Therapeutics

Link
Pink Sheet

17 Sep 2020

Deadly COVID-19 Hand Sanitizer Production Surge Prompted US FDA's New Import Alert Category

Link
HBW Insight

17 Sep 2020

Cosmetic Microbeads A Drop In The Bucket Compared With Possible EU Microplastic Restriction Impacts

Link
Generics Bulletin

17 Sep 2020

EPO Reversal Overturns Copaxone 40mg Patent

Link
Pink Sheet

17 Sep 2020

340B Showdown: HHS Facing Mounting Congressional Pressure To Halt Pharma Challenges

Link
HBW Insight

17 Sep 2020

Cosmetic And Personal Care Trademark Review 15 September, 2020

Link
Generics Bulletin

17 Sep 2020

Sandoz Among Winners As US Court Applies Tecfidera Patent Invalidity Ruling

Link
HBW Insight

17 Sep 2020

Apple Series 6 Watch Pumps Mobile Access To Blood Oxygen Saturation Measurement

Link
Scrip

17 Sep 2020

Double Dose: After Stelis, Strides Readies SteriScience For Injectables Push

Link
Pink Sheet

17 Sep 2020

US FDA Assesses Over 500 Biopharma Plants Remotely Via Records Review; Refines Process

Link
Pink Sheet

17 Sep 2020

World First Or Beating The US? China Ups COVID-19 Vaccines Game

Link
Medtech Insight

17 Sep 2020

Refined FDA Analysis Report Finds 2 Fewer Deaths Linked To Essure

Link

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

How can we help you?

Our team is always happy to hear from you. Please call us at:

US Toll-Free : +1 888 670 8900
US Toll : +1 908 547 2200
UK & Europe : +44 (20) 337 73737
Australia : +61 2 8705 6907
Japan : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Tailor-made Pharma Solutions

Tailor-made solutions

Pharma Intelligence latest insights

The Rise of Digital Tools eBook

Pharma Intelligence Launches Alexa Skill

The Future of Clinical Trials From the Investigator Perspective Webinar

Germany's Supplements Market Boosted By COVID-19

WHO's Latest COVID Recommendations Show Generic Potential

COVID-19: CDRH Staff Leaves Door Open For Some LDT Safety Oversight

Qiagen Ready To Rival Abbott With Rapid Portable Antigen COVID-19 Test

Pharma Stands Up To Trump Pressure With COVID-19 Vaccines Science Pledge

AstraZeneca's COVID Vaccine On Hold: A Reminder Drug Development Is Never Straightforward

UK Votes To Leave The EU – Where Next For The Life Sciences?

Time Is Short To Prepare For New Post-Brexit UK Regulation

UKCA Mark Will Be The Post-EU Route To The British Medtech Market In January 2021

Brexit Response: Patient Safety Prioritized In Forthcoming UK MHRA Device Regulatory System

UK Explains Approach To Renewing Converted EU Drug Approvals in 2021

Gloom Over Prospects For Brexit Trade Deal

Latest headlines

Five More Circle Tecfidera With Ruling 'Unlikely To Be Reversed'

EMA Aims For Better Info On Benefit-Risk Balance To Support Drug Choices In Pregnancy

Moderna Expands Horizons With Vertex and Chiesi Deals

Executives On The Move: Changes At The Top At Silence Therapeutics

Deadly COVID-19 Hand Sanitizer Production Surge Prompted US FDA's New Import Alert Category

Cosmetic Microbeads A Drop In The Bucket Compared With Possible EU Microplastic Restriction Impacts

EPO Reversal Overturns Copaxone 40mg Patent

340B Showdown: HHS Facing Mounting Congressional Pressure To Halt Pharma Challenges

Cosmetic And Personal Care Trademark Review 15 September, 2020

Sandoz Among Winners As US Court Applies Tecfidera Patent Invalidity Ruling

Apple Series 6 Watch Pumps Mobile Access To Blood Oxygen Saturation Measurement

Double Dose: After Stelis, Strides Readies SteriScience For Injectables Push

US FDA Assesses Over 500 Biopharma Plants Remotely Via Records Review; Refines Process

World First Or Beating The US? China Ups COVID-19 Vaccines Game

Refined FDA Analysis Report Finds 2 Fewer Deaths Linked To Essure

Next steps

This is Contactus Section

Request a live demo

How can we help you?

Pharma Report Store